Director of Engineering, myTomorrows
Helping patients discover and access treatments
Job no longer available
Helping patients discover and access treatments
101-200 employees
Job no longer available
101-200 employees
Company mission
To enable earlier and better access to all possible treatment options.
Role
Who you are
- Are a skilled and experienced professional looking for an exciting opportunity to lead a team and drive product development in a dynamic tech startup
- Love to showcase your expertise in team leadership and in-depth knowledge of our tech stack
- Have familiarity with building a tech platform
- Excellent English communication skills
- The ability to build trust and work well with a diverse group, internally and externally
- Critical thinking skills, the ability to quickly gain an understanding of business situations and identify root-causes
- Organization skills, and detail orientation, with great follow-through on objectives/projects
What the job involves
- Managing and leading a team of engineers and data scientists: This includes recruiting, hiring, and onboarding new team members, as well as setting goals and providing guidance and mentorship to the team
- Working closely together with other disciplines: this includes product management, design, and growth team
- Overseeing all technical aspects of our products. This includes code quality, efficiency, and scalability, as well as architecture, security and performance
- Communicating with stakeholders, such as keeping upper management and other stakeholders informed of the engineering team's progress, and communicating any issues or concerns that arise
- Continuously improving the engineering team, by identifying areas where the team can improve, and implementing processes and tools to help the team work more efficiently and effectively
Our take
In Europe alone there are around 1 million patients with debilitating diseases who have few or no treatment options for their conditions. For many, experimental drugs may hold the key to effective treatment, but an alarming 95% of such patients will not meet the eligibility criteria to enter clinical trials for these potentially life-improving medications. For patients who cannot wait for new drugs to become fully approved and available, it has historically been very difficult to access treatments in development.
This is what myTomorrows has set out to change. Founded in 2012, myTomorrows is a platform that helps patients and physicians discover and access treatments in development. It charges pharmaceutical companies for its services in assisting with clinical trials, but for patients and physicians its services are free. With a model based on encouraging reciprocity, myTomorrows is looking to disrupt this market in a holistic way - changing things for the better and benefitting all sides.
With over 5000 patients helped, 500+ physician partners onboard, and access to over 300,000 clinical research studies, myTomorrows has managed to generate some impressive early metrics. This has attracted big investor interest, and myTomorrows is planning on using new funding to invest in new technology and increase its headcount.
In terms of market trends, the 'right to try' debate is still fierce across the world, but the shift in the last 20 years has clearly been towards liberalisation, especially in the US. It looks, then, like myTomorrows' prospects are going to get even stronger in the coming years.
Kirsty
Company Specialist at Welcome to the Jungle
Insights
23% employee growth in 12 months
Company
Funding (last 2 of 5 rounds)
Nov 2025
$29m
LATE VC
Jan 2017
$11.6m
SERIES A
Total funding: $51.8m
Company benefits
- International work environment, scale-up energy, and flat organization
- Great career development opportunities in a growing company
- Learning and development budget, alongside internal knowledge-sharing sessions
- Attractive pension plan, full premium covered by us
- Hybrid work model
- Policies to support working parents
- Healthy lunch at the office
- Unlimited access to professional guidance by certified psychologists via OpenUp
- We celebrate freedom every year with an added holiday for Liberation Day on the 5th of May
Company HQ
Hoofddorppleinbuurt, Amsterdam, NH
Leadership
Ronald Brus
(Founder & CEO)A physician by trade, Ronald is also the co-founder and CBO of Leyden Labs, and spent over 14 years at biotech company Crucell.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job